Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.

Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.
复制标题

DOI:
10.1038/s41541-021-00419-z
复制
发表时间:
2021-12-20
期刊:
影响因子:
9.2
通讯作者:
Fomsgaard A
Fomsgaard A
中科院分区:
医学1区
文献类型:
--
作者:
Lassaunière R;Polacek C;Gram GJ;Frische A;Tingstedt JL;Krüger M;Dorner BG;Cook A;Brown R;Orekov T;Putmon-Taylor T;Campbell TA;Greenhouse J;Pessaint L;Andersen H;Lewis MG;Fomsgaard A

文献摘要

参考文献

被引文献

相似文献

新一代质粒DNA疫苗可能是一种安全、快速、简便的应急疫苗平台,用于预防新出现的病毒性病原体。应用平台优化策略,我们测试了一种针对严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)的候选DNA质粒疫苗的临床前免疫原性和保护效果。该DNA疫苗在小鼠、兔和恒河猴中诱导尖峰特异性结合IgG和中和抗体,以及在小动物中诱导稳健的Th 1优势细胞应答。皮内和肌内无针注射DNA疫苗产生了相当的免疫应答。在一项对恒河猴进行的疫苗接种-攻毒研究中,证明了在鼻内和肺内接种SARS-CoV-2后,疫苗可防止病毒在肺中复制。总之,编码SARS-CoV-2刺突蛋白的候选质粒DNA疫苗在不同模型中具有免疫原性,并在非人灵长类动物中赋予针对肺部感染的保护。需要在临床试验中进一步评估这种DNA疫苗候选物。
New generation plasmid DNA vaccines may be a safe, fast and simple emergency vaccine platform for preparedness against emerging viral pathogens. Applying platform optimization strategies, we tested the pre-clinical immunogenicity and protective effect of a candidate DNA plasmid vaccine specific for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The DNA vaccine induced spike-specific binding IgG and neutralizing antibodies in mice, rabbits, and rhesus macaques together with robust Th1 dominant cellular responses in small animals. Intradermal and intramuscular needle-free administration of the DNA vaccine yielded comparable immune responses. In a vaccination-challenge study of rhesus macaques, the vaccine demonstrated protection from viral replication in the lungs following intranasal and intratracheal inoculation with SARS-CoV-2. In conclusion, the candidate plasmid DNA vaccine encoding the SARS-CoV-2 spike protein is immunogenic in different models and confers protection against lung infection in nonhuman primates. Further evaluation of this DNA vaccine candidate in clinical trials is warranted.
DOI: 10.1016/j.vaccine.2009.02.061
发表时间: 2009-04-21
期刊: VACCINE
影响因子: 5.5
作者:
Jones, Suzanne;Evans, Kirsten;Loudon, Peter T.
通讯作者: Loudon, Peter T.
DOI: 10.1084/jem.20071331
发表时间: 2008-01-21
影响因子: 15.3
作者:
Harari, Alexandre;Bart, Pierre-Alexandre;Stoehr, Wolfgang;Tapia, Gonzalo;Garcia, Miguel;Medjitna-Rais, Emmanuelle;Burnet, Severine;Cellerai, Cristina;Erlwein, Otto;Barber, Tristan;Moog, Christiane;Liljestrom, Peter;Wagner, Ralf;Wolf, Hans;Kraehenbuhl, Jean-Pierre;Esteban, Mariano;Heeney, Jonathan;Frachette, Marie-Joelle;Tartaglia, James;McCormack, Sheena;Babiker, Abdel;Weber, Jonathan;Pantaleo, Giuseppe
通讯作者: Pantaleo, Giuseppe
DOI: 10.3390/microorganisms9051040
发表时间: 2021-05-12
期刊: Microorganisms
影响因子: 4.5
作者:
Leventhal SS;Clancy C;Erasmus J;Feldmann H;Hawman DW
通讯作者: Hawman DW
DOI: 10.1016/j.vaccine.2020.10.064
发表时间: 2020-11-25
期刊: Vaccine
影响因子: 5.5
作者:
Guebre-Xabier M;Patel N;Tian JH;Zhou B;Maciejewski S;Lam K;Portnoff AD;Massare MJ;Frieman MB;Piedra PA;Ellingsworth L;Glenn G;Smith G
通讯作者: Smith G
DOI: 10.1038/s41541-020-00279-z
发表时间: 2021-01-25
期刊: NPJ vaccines
影响因子: 9.2
作者:
Brocato RL;Kwilas SA;Kim RK;Zeng X;Principe LM;Smith JM;Hooper JW
通讯作者: Hooper JW